Stereotactic body radiation therapy for locally advanced and borderline resectable pancreatic cancer is effective and well tolerated

International Journal of Radiation Oncology Biology Physics

Volumn 86, Issue 3, 2013, Pages 516-522

  Chuong, Michael D ^a   Springett, Gregory M ^a   Freilich, Jessica M ^a   Park, Catherine K ^a   Weber, Jill M ^a   Mellon, Eric A ^a   Hodul, Pamela J ^a   Malafa, Mokenge P ^a   Meredith, Kenneth L ^a   Hoffe, Sarah E ^a   Shridhar, Ravi ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOTHERAPY; DISEASES; PATIENT TREATMENT; TOXICITY; TUMORS;

DOSE PAINTINGS; INDUCTION CHEMOTHERAPY; LOCALLY ADVANCED PANCREATIC CANCERS; METHODS AND MATERIALS; OVERALL SURVIVAL; PANCREATIC CANCERS; PROGRESSION FREE SURVIVAL; STEREOTACTIC BODY RADIATION THERAPY;

RADIOTHERAPY;

CA 19-9 ANTIGEN; CAPECITABINE; DOCETAXEL; FLUOROURACIL; FOLINIC ACID; GEMCITABINE; IRINOTECAN; OXALIPLATIN;

ADULT; ADVANCED CANCER; AGED; ANASTOMOSIS LEAKAGE; ARTICLE; BILIARY STENT; CLINICAL EFFECTIVENESS; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; DISTANT METASTASIS; DOSIMETRY; DRUG DOSE REGIMEN; FEMALE; FOLLOW UP; HUMAN; INDUCTION CHEMOTHERAPY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OVERALL SURVIVAL; PANCREAS CANCER; PANCREAS RESECTION; PANCREATICODUODENECTOMY; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIATION DOSE FRACTIONATION; RADIATION SAFETY; RETROSPECTIVE STUDY; SPLENECTOMY; STEREOTACTIC BODY RADIATION THERAPY; SUPERIOR MESENTERIC VEIN; TREATMENT PLANNING; VERY ELDERLY; WOUND DEHISCENCE; WOUND INFECTION; YOUNG ADULT; ADJUVANT CHEMOTHERAPY; CANCER STAGING; COMPUTER ASSISTED RADIOTHERAPY; DISEASE FREE SURVIVAL; FIDUCIAL MARKER; FOUR DIMENSIONAL COMPUTED TOMOGRAPHY; METHODOLOGY; MORTALITY; PANCREAS TUMOR; PATHOLOGY; RADIOSURGERY;

ADULT; AGED; AGED, 80 AND OVER; CHEMOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; FEMALE; FIDUCIAL MARKERS; FOUR-DIMENSIONAL COMPUTED TOMOGRAPHY; HUMANS; INDUCTION CHEMOTHERAPY; MALE; MIDDLE AGED; NEOPLASM STAGING; PANCREATIC NEOPLASMS; RADIOSURGERY; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RETROSPECTIVE STUDIES;

MLCS; MLOWN;

EID: 84880635783     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2013.02.022     Document Type: Article

References (20)

1. LiD,XieK,Wolff R, et al.Pancreatic cancer. Lancet 2004;363:1049-1057.
2. Treatment of locally unresectable carcinoma of the pancreas: Comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone. Gastrointestinal Tumor Study Group. J Natl Cancer Inst 1988;80:751-755.
3. Patel M, Hoffe S, Malafa M, et al. Neoadjuvant GTX chemotherapy and IMRT-based chemoradiation for borderline resectable pancreatic cancer. J Surg Oncol 2011;104:155-161.
4. Huguet F, Andre T, Hammel P, et al. Impact of chemoradiotherapy after disease control with chemotherapy in locally advanced pancreatic adenocarcinoma in GERCOR phase II and III studies. J Clin Oncol 2007;25:326-331.
5. Ko AH, Quivey JM, Venook AP, et al. A phase II study of fixed-dose rate gemcitabine plus low-dose cisplatin followed by consolidative chemoradiation for locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 2007;68:809-816.
6. Koong AC, Christofferson E, Le QT, et al. Phase II study to assess the efficacy of conventionally fractionated radiotherapy followed by a stereotactic radiosurgery boost in patients with locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 2005;63:320-323.
7. Koong AC, Le QT, Ho A, et al. Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 2004;58:1017-1021.
8. Schellenberg D, Kim J, Christman-Skieller C, et al. Single-fraction stereotactic body radiation therapy and sequential gemcitabine for the treatment of locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 2011;81:181-188.
9. Schellenberg D, Goodman KA, Lee F, et al. Gemcitabine chemotherapy and single-fraction stereotactic body radiotherapy for locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 2008;72: 678-686.
10. Mahadevan A, Miksad R, Goldstein M, et al. Induction gemcitabine and stereotactic body radiotherapy for locally advanced nonmetastatic pancreas cancer. Int J Radiat Oncol Biol Phys 2011;81: e615-e622.
11. Mahadevan A, Jain S, Goldstein M, et al. Stereotactic body radiotherapy and gemcitabine for locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 2010;78:735-742.
12. Polistina F, Costantin G, Casamassima F, et al. Unresectable locally advanced pancreatic cancer: A multimodal treatment using neoadjuvant chemoradiotherapy (gemcitabine plus stereotactic radiosurgery) and subsequent surgical exploration. Ann Surg Oncol 2010; 17:2092-2101.
13. Rwigema JC, Parikh SD, Heron DE, et al. Stereotactic body radiotherapy in the treatment of advanced adenocarcinoma of the pancreas. Am J Clin Oncol 2011;34:63-69.
14. Didolkar MS, Coleman CW, Brenner MJ, et al. Image-guided stereotactic radiosurgery for locally advanced pancreatic adenocarcinoma results of first 85 patients. J Gastrointest Surg 2010;14:1547-1559.
15. Chang DT, Schellenberg D, Shen J, et al. Stereotactic radiotherapy for unresectable adenocarcinoma of the pancreas. Cancer 2009;115: 665-672.
16. Chuong M, Springett G, Weber J, et al. Induction gemcitabine-based chemotherapy and neoadjuvant stereotactic body radiation therapy achieve high margin-negative resection rates for borderline resectable pancreatic cancer. J Radiat Oncol 2012;1(3):273-281.
17. Millikan KW, Deziel DJ, Silverstein JC, et al. Prognostic factors associated with resectable adenocarcinoma of the head of the pancreas. Am Surg 1999;65:618-623. discussion 623-614.
18. Hoyer M, Roed H, Sengelov L, et al. Phase-II study on stereotactic radiotherapy of locally advanced pancreatic carcinoma. Radiother Oncol 2005;76:48-53.
19. Katz MH, Pisters PW, Evans DB, et al. Borderline resectable pancreatic cancer: The importance of this emerging stage of disease. J Am Coll Surg 2008;206:833-846. discussion 846-838.
20. Murphy JD, Chang DT, Abelson J, et al. Cost-effectiveness of modern radiotherapy techniques in locally advanced pancreatic cancer. Cancer 2012;118:1119-1129.